Sysmex Cor (6869)

Currency in JPY
1,542.5
-7.5(-0.48%)
Closed·
6869 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,537.51,573.0
52 wk Range
1,435.03,063.0
Key Statistics
Bid/Ask
1,542.50 / 1,545.00
Prev. Close
1,550
Open
1,572.5
Day's Range
1,537.5-1,573
52 wk Range
1,435-3,063
Volume
2.79M
Average Volume (3m)
3.53M
1-Year Change
-47.11%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6869 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2,344.4
Upside
+51.99%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry

Sysmex Cor News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Sysmex Cor Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Employees
10533
Market
Japan

Sysmex Cor Earnings Call Summary for Q2/2026

  • Sysmex missed Q2 2025 forecasts with EPS of 23.2 (vs 24.06 expected) and revenue of ¥126.8B (vs ¥132.89B expected), causing shares to drop 5.65% after hours to ¥1610.
  • The company revised its full-year sales forecast downward to ¥510B and operating income to ¥76B, while improving Q2 operating income ratio to 17.6%.
  • Key challenges include yen depreciation, Chinese market conditions, geopolitical concerns in META region, and US supply chain issues with tariff impacts.
  • Growth opportunities exist in emerging markets like India and Brazil, with planned European market entry for Hinotori medical robot and expansion of hemostasis business in Europe and US.
  • Management expects recovery in Japanese and Chinese markets next year, while focusing on comprehensive laboratory solutions and establishing a training center for Hinotori.
Last Updated: 20/11/2025, 11:56
Read Full Transcript

Compare 6869 to Peers and Sector

Metrics to compare
6869
Peers
Sector
Relationship
P/E Ratio
20.6x21.5x−0.6x
PEG Ratio
−1.640.580.00
Price/Book
2.0x2.3x2.6x
Price / LTM Sales
1.9x2.2x3.2x
Upside (Analyst Target)
47.5%11.8%43.5%
Fair Value Upside
Unlock4.2%5.7%Unlock

Analyst Ratings

12 Buy
4 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2,344.4
(+51.99% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy2,100.00+36.14%2,500.00Maintain18/12/2025
Nomura/Instinet
Buy3,000.00+94.49%3,600.00Maintain26/11/2025
Macquarie
Hold2,000.00+29.66%2,200.00Maintain14/10/2025
Goldman Sachs
Buy2,400.00+55.59%2,500.00Upgrade10/10/2025
JPMorgan
Buy2,500.00+62.07%3,000.00Maintain02/10/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 74.85%
Dividend Yield
2.46%
Industry Median 1.58%
Annualised payout
38.00
Paid unevenly
5-Years Growth
+7.84%
Growth Streak

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
23.20 / 24.06
Revenue / Forecast
126.80B / 132.89B
EPS Revisions
Last 90 days

People Also Watch

3,780.0
6324
+5.44%
1,983.0
6724
-1.02%
166.0
8729
-1.43%

FAQ

What Is the Sysmex Cor (6869) Share Price Today?

The live Sysmex Cor share price today is 1,542.5

What Stock Exchange Does Sysmex Cor (6869) Trade On?

Sysmex Cor is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for Sysmex Cor?

The stock symbol (also called a 'ticker') for Sysmex Cor is "6869."

Does Sysmex Cor Pay Dividends? What’s The Current 6869 Dividend Yield?

Yes, 6869 Pays Dividends to its Shareholders. The current Sysmex Cor dividend yield is 2.46%.

What Is the Current Sysmex Cor Market Cap?

As of today, Sysmex Cor market capitalisation is 961.93B.

What Is Sysmex Cor's (6869) Earnings Per Share (TTM)?

The Sysmex Cor EPS is currently 74.85 (Trailing Twelve Months).

When Is the Next Sysmex Cor Earnings Date?

Sysmex Cor's next earnings report will be released on 05 Feb 2026.

Is 6869 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Sysmex Cor moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Sysmex Cor Stock Split?

Sysmex Cor has split 4 times. (See the 6869 stock split history page for full effective split date and price information.)

How Many Employees Does Sysmex Cor Have?

Sysmex Cor has 10533 employees.

What is the current trading status of Sysmex Cor (6869)?

As of 03 Jan 2026, Sysmex Cor (6869) is trading at a price of 1,542.5, with a previous close of 1,550.0. The stock has fluctuated within a day range of 1,537.5 to 1,573.0, while its 52-week range spans from 1,435.0 to 3,063.0.

What Is Sysmex Cor (6869) Price Target According to Analysts?

The average 12-month price target for Sysmex Cor is JPY2344.375, with a high estimate of JPY3300 and a low estimate of JPY1650. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +51.99% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.